Effect of periodontal treatment on glycosylated hemoglobin levels in elderly patients with periodontal disease and type 2 diabetes

Chinese Medical Journal

Volumn 124, Issue 19, 2011, Pages 3070-3073

  Long, Ou ^a   Ru Fan, Li ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Glycosylated hemoglobin; Periodontal disease; Type 2 diabetes

Indexed keywords

ANTIINFLAMMATORY AGENT; GLUCOSE; GLYCEROL; HEMOGLOBIN A1C; IODINE; PERIOCLINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DISEASE CONTROL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; PERIODONTAL DISEASE; PERIODONTAL EXAMINATION; PERIODONTAL THERAPY;

AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PERIODONTAL DISEASES;

EID: 80053552475     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.19.022     Document Type: Article

References (22)

1. Preshaw PM, de Silva N, McCracken GI, Fernando DJ, Dalton CF, Steen ND, et al. Evaluation of the relationship between type 2 diabetes and periodontal disease. J Clin Periodontol 2010; 37: 165-171.
2. Wolff RE, Wolff LF, Michalowicz BS. A pilot study of glycosylated hemoglobin levels in periodontitis cases and healthy controls. J Periodontol 2009; 80: 1057-1061.
3. Sako E, Hosomichi J. Alteration of bFGF expression with growth and age in rat molar periodontal ligament. Angle Orthod 2010; 80: 904-911.
4. Miller LS, Manwell MA, Newbold D, Reding ME, Rasheed A, Blodgett J, et al. The relationship between reduction in periodontal inflammation and diabetes control: a report of 9 class. J Periodontal 1992; 63: 843-848.
5. Navarro-Sanchez AB, Faria-Almeida R, Bascones-Martinez A. Effect of non-surgical periodontal therapy on clinical and immunological response and glycaemic control in type 2 diabetic patients with moderate periodontitis. J Clin Periodontol 2007; 34: 835-843.
6. da Cruz GA, de Toledo S, Sallum EA, Sallum AW, Ambrosano GM, de Cássia Orlandi Sardi J, et al. Clinical and laboratory evaluations of non-surgical periodontal treatment in subjects with diabetes mellitus. J Periodontol 2008; 79: 1150-1157.
7. Chew EY, Ambrosius WT, Davis MD, Danis RP, Gangaputra S, Greven CM; ACCORD Study Group; ACCORD Eye Study Group. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 2010; 363: 233-244.
8. Crook M. Type 2 diabetes mellitus A disease of the innate immune system? An update. Diabed Med 2004; 21: 203-207.
9. Correa FO, Gonçalves D, Figueredo CM, Bastos AS, Gustafsson A, Orrico SR. Effect of periodontal treatment on metabolic control, systemic inflammation and cytokines in patients with type 2 diabetes. J Clin Periodontol 2010; 37: 53-58.
10. Rethman MP. Inflammation in chronic periodontitis and significant systemic diseases. J Calif Dent Assoc 2010; 38: 247-257.
11. Salonen LW, Frithiof L, Wouters FR, Helldén LB. Marginal alveolar bone height in an adult Swidish population. A radiographic cross-sectional epidemiologic study. J Periodontal 1991; 18: 223-232.
12. Tervonen T, Knuuttila M, Pohjamo L, Nurkkala H. Immediate response to non-surgical periodontal treatment in subjects with diabetes mellitus. J Clin Periodontal 1991; 18: 65-68.
13. Kiran M, Arpak N, Unsal E, Erdoǧan MF. The effect of improved periodontal health on metabolic control in type 2 diabetes. J Clin Periodontal 2005; 32: 266-272.
14. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-2415.
15. Zheng W, Wang S, Ma D, Tang L, Duan Y, Jin Y. Loss of proliferation and differentiation capacity of aged human periodontal ligament stem cells and rejuvenation by exposure to the young extrinsic environment. Tissue Eng Part A 2009; 15: 2363-2371.
16. Simpson TC, Needleman I, Wild SH, Moles DR, Mills EJ. Treatment of periodontal disease for glycaemic control in people with diabetes. Cochrane Database Syst Rev 2010; 5: CD004714.
17. Daǧ A, Firat ET, Arikan S, Kadiroǧlu AK, Kaplan A. The effect of periodontal therapy on serum TNF-alpha and HbA1c levels in type 2 diabetic patients. Aust Dent J 2009; 54: 17-22.
18. Talbert J, Elter J, Jared HL, Offenbacher S, Southerland J, Wilder RS. The effect of periodontal therapy on TNF-alpha, IL-6 and metabolic control in type 2 diabetics. J Dent Hyg 2006; 80: 7.
19. Shin DS, Park JW, Suh JY, Lee JM. The expressions of inflammatory factors and tissue inhibitor of matrix metalloproteinase-2 in human chronic periodontitis with type 2 diabetes mellitus. J Periodontal Implant Sci 2010; 40: 33-38.
20. Correa FO, Gonçalves D, Figueredo CM, Bastos AS, Gustafsson A, Orrico SR. Effect of periodontal treatment on metabolic control, systemic inflammation and cytokines in patients with type 2 diabetes. J Clin Periodontol 2010; 37: 53-58.
21. Huttner EA, Machado DC, de Oliveira RB, Antunes AG, Hebling E. Effects of human aging on periodontal tissues. Spec Care Dentist 2009; 29: 149-155.
22. Promsudthi A, Pimapansri S, Deerochanawong C, Kanchanavasita W. The effect of periodontal therapy on uncontrolled type 2 diabetes mellitus in older subjects. Oral Dis 2005; 11: 293-298.